Hypersensitivity to the active substances, to egg, fish, peanut or soya protein or to any of the excipients listed in Description; Inborn errors of amino acid metabolism; Severe hyperlipidaemia characterized by hypertriglyceridaemia (≥1000 mg/dL or 11.4 mmol/L); Severe coagulopathy; Hyperglycaemia not responding to insulin doses of up to 6 units insulin/hour; Acidosis; Intrahepatic cholestasis; Severe hepatic insufficiency; Severe renal insufficiency in absence of renal replacement therapy; Aggravating haemorrhagic diatheses; Acute thromboembolic events, lipid embolism.
On account of its composition, OMEGAFLEX Peri Emulsion for Infusion/OMEGAFLEX Special Emulsion for Infusion must not be used in newborn infants, infants and toddlers under 2 years of age.
General contraindications to parenteral nutrition include: unstable circulatory status with vital threat (states of collapse and shock); acute phases of cardiac infarction and stroke; unstable metabolic condition (e.g. severe post-aggression syndrome, coma of unknown origin); inadequate cellular oxygen supply; disturbances of the electrolyte and fluid balance; acute pulmonary oedema; decompensated cardiac insufficiency.